China NMPA approves Keymed Biosciences’ sNDA for Stapokibart to treat chronic rhinosinusitis with nasal polyposis: Chengdu, China Thursday, December 26, 2024, 18:00 Hrs [IST] Ke ...
OBI Pharma inks agreements with GlyTech to expand GlycOBI enabling technologies in Japan to advance Glycan production: Taipei, Taiwan Thursday, December 26, 2024, 17:00 Hrs [IST] ...
Sanofi and SK bioscience have entered into a new chapter of their collaboration in pneumococcal vaccines with an expanded agreement to develop, license and commercialize next-generation PCVs for both ...
Quantum-Si submits new paper to bioRxiv; demonstrates advances in protein variant detection using ProteoVue with next-generation protein sequencing: Branford, Conn. Thursday, Dece ...
Rhythm receives US FDA nod for IMCIVREE to reduce excess body weight & maintain weight reduction long-term in children 2 years old: Boston, MA Thursday, December 26, 2024, 14:00 H ...
The Parliamentary panel that looked into the budget allocation for the Department of Pharmaceuticals (DoP) and related matters has recommended to the government to enhance its existing incentives for ...
An expert workgroup representing primary and specialty care has developed new guidelines for comprehensive evaluation of patients who may have cognitive impairment or dementia due to Alzheimer’s ...
Basilea Pharma awarded USD 7.3 million additional CARB-X funding to develop new drug candidate from a novel class of antibiotics: Allschwil, Switzerland Thursday, December 26, 202 ...